Okay, here's a summarized bullet-list version of the "Infectious Disease Puscast #75" transcript, incorporating timestamps, important details, and key takeaways, as requested:

Infectious Disease Puscast #75: Summary

• 0:00 Introduction: Drs. Daniel Griffin and Sara Dong introduce the podcast, covering infectious disease literature from February 13-26, 2025.

• 2:09 Viral: Chikungunya Vaccine (VIMKUNYA): The FDA approved Bavarian Nordic's single-dose chikungunya vaccine, VIMKUNYA, for those 12+ at increased risk. Discussion of potential rollout in travel clinics and endemic areas.

• 3:17 Viral: Measles Outbreak: Discussion of the large and growing Texas measles outbreak (124 cases, 18 hospitalizations, at least one pediatric death). Links provided to Texas and New Mexico Department of Health resources. The outbreak is the largest in the US in modern history. The hosts mention children are dying from measles. Mention of a "Beyond the Noise" episode with Paul Offit for context on vaccine hesitancy.

• 7:51 Viral: Febrile Episode: Reference to a previous febrile episode that the hosts did, covering measles.

• 8:10 Viral: Influenza Antiviral Timing (CID): Study emphasizing the importance of early oseltamivir (Tamiflu) treatment in hospitalized influenza patients with pneumonia. Starting on day 0 (admission) significantly reduces 30-day mortality (7.5%) compared to day 1 (8.5%) or days 2-5 (over 10%). A 40% reduction compared to waiting 48 hours.

• 11:22 Viral: HIV Mother-Child Dyads (Journal of the International AIDS Society): Study in South Africa: less than half of children with HIV on ART achieved virologic suppression at 2 years. Underscores vulnerabilities in pediatric HIV care and the importance of supporting both mothers and children.

• 13:48 Viral: PEPFAR Stop-Work Order (Journal of the International AIDS Society): Early assessment of the Trump administration's executive order freezing foreign assistance funds (including PEPFAR). Predicts hundreds of thousands losing access to HIV treatment, program closures, and irreversible damage.

• 17:10 Viral: Arbovirus Infections in Southeast Europe (Lancet Infectious Diseases): Prospective study (MERMAIDS-ARBO) on hospitalized adults with arbovirus illness. Found under-detection by local labs compared to reference labs. West Nile, Toscana, and tick-borne encephalitis viruses were identified.

• 21:55 Bacterial: Extended Anaerobic Antibiotic Coverage (International Journal of Infectious Diseases): Retrospective study found no significant difference in 30-day mortality between extended and limited anaerobic antibiotic coverage in anaerobic bloodstream infections. Source control significantly reduced mortality risk.

• 23:59 Bacterial: Newer Beta-Lactams for Gram-Negative Meningitis (CID): Review article summarizing data on newer beta-lactams (cefiderocol, ceftazidime-avibactam, etc.) for treating resistant gram-negative meningitis. Provides recommendations on drug selection based on CSF penetration and available evidence.

• 27:45 Bacterial: Macrolide-Resistant Mycoplasma Pneumoniae (Pediatric Infectious Disease Journal): Meta-analysis showing tetracycline treatment (minocycline, doxycycline) is superior to macrolide treatment (azithromycin, clarithromycin) in children with macrolide-resistant Mycoplasma pneumoniae pneumonia.

• 30:54 Fungal: Reference made to the paper, Concordance of non-invasive plasma cell-free DNA With invasive diagnostics for diagnosis of invasive fungal disease.

• 32:18 Fungal: Invasive Fungal Infections in Liver Disease (Intensive Care Medicine): Review article on invasive fungal infections (Candida, Aspergillus, Cryptococcus) in liver disease, discussing immunological defects and clinical management in the ICU.

• 34:54 Parasitic: Protozoa and Helminths in Starr County, Texas (American J Trop Med and Hyg): Cross-sectional study found Blastocystis (13.4%), Giardia (0.8%), and Strongyloides (0.3%) in adults. Associated with age, lack of insurance, and living outside a "Colonia" (low-income slum area).

• 36:32 Parasitic: Post-Artesunate Delayed Hemolysis (CID): Study in African children with severe malaria. Post-artesunate delayed hemolysis occurred in 23%. Associated with increased hospitalization and infectious events. Liberal blood transfusion policy reduced incidence.

• 38:52 Miscellaneous: Telehealth Changes: Starting April 1, 2025, Medicare telehealth services will be restricted to rural areas, potentially limiting access, especially to infectious disease specialists.

• 40:01 Miscellaneous: IDSA Guideline Public Comment: Public comment period open for the 2025 updated IDSA guideline on the management and treatment of complicated urinary tract infections (cUTIs).

• 42:09 Call for Support: Hosts stress the need for listener support for science communication, as it is under attack, and misinformation is prevalent.